- Home
- YCBD vs CDIO Comparison
YCBD vs CDIO Comparison
Compare YCBD & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- CDIO
- Stock Information
- Founded
- YCBD 2015
- CDIO 2017
- Country
- YCBD United States
- CDIO United States
- Employees
- YCBD N/A
- CDIO N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- YCBD Health Care
- CDIO Health Care
- Exchange
- YCBD Nasdaq
- CDIO Nasdaq
- Market Cap
- YCBD 7.8M
- CDIO 6.4M
- IPO Year
- YCBD N/A
- CDIO N/A
- Fundamental
- Price
- YCBD $1.49
- CDIO $4.53
- Analyst Decision
- YCBD Strong Buy
- CDIO
- Analyst Count
- YCBD 1
- CDIO 0
- Target Price
- YCBD $2.00
- CDIO N/A
- AVG Volume (30 Days)
- YCBD 11.0M
- CDIO 40.3K
- Earning Date
- YCBD 08-14-2025
- CDIO 11-12-2025
- Dividend Yield
- YCBD N/A
- CDIO N/A
- EPS Growth
- YCBD N/A
- CDIO N/A
- EPS
- YCBD N/A
- CDIO N/A
- Revenue
- YCBD $19,026,064.00
- CDIO $19,507.00
- Revenue This Year
- YCBD $0.37
- CDIO $1,434.82
- Revenue Next Year
- YCBD $4.95
- CDIO $4,661.91
- P/E Ratio
- YCBD N/A
- CDIO N/A
- Revenue Growth
- YCBD N/A
- CDIO N/A
- 52 Week Low
- YCBD $0.59
- CDIO $3.22
- 52 Week High
- YCBD $6.54
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- YCBD 72.63
- CDIO 61.83
- Support Level
- YCBD $0.60
- CDIO $4.16
- Resistance Level
- YCBD $1.94
- CDIO $4.63
- Average True Range (ATR)
- YCBD 0.23
- CDIO 0.35
- MACD
- YCBD 0.07
- CDIO 0.04
- Stochastic Oscillator
- YCBD 64.18
- CDIO 70.62
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.